Virtual Vision Health, a leader in Virtual Reality (VR) eye care technology, announced today the launch of Visual Acuity testing on the Virtual Eye VR platform. This enhancement marks a significant ...

This article is sponsored by Smartlinx. In this Voices interview, Skilled Nursing News sits down with Mark Stoever, CEO of ...

The New Brunswick Medical Society is calling on Horizon Health Network and the Department of Health to cancel the virtual ...

This echoed a guiding principle in my life that for years I have called upon, the Serenity Prayer: “God grant me the serenity ...

Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced the ...

The hospital has started using an artificial intelligence program from a company called Nabla to help doctors take notes on ...

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

The following is a summary of “ALS Motor Observational Telemedicine Objective Rasch-Built Assessment,” published in the ...

AIIMS to launch a neurotechnology facility with the Vattikuti Foundation, featuring non-invasive MRgFUS treatment for ...